🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Preterm neonates are fragile to infections. Their immune system is immature...
Status
Unknown
Location
Centre Hospitalier Regional et Universitaire, Maternite Regionale
Start Date
2014-01
Trial ID
NCT02179996
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
The purpose of this study is to determine the safety and efficacy of a PEPI...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2025-07-15
Trial ID
NCT05609994
Treatments Being Tested
The purpose of this study is to investigate for the broad immunological eff...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT02710045
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested